Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies

  1. Abaza, Y.M.
  2. Kadia, T.M.
  3. Jabbour, E.J.
  4. Konopleva, M.Y.
  5. Borthakur, G.
  6. Ferrajoli, A.
  7. Estrov, Z.
  8. Wierda, W.G.
  9. Alfonso, A.
  10. Chong, T.H.
  11. Chuah, C.
  12. Koh, L.-P.
  13. Goh, B.-C.
  14. Chang, J.E.
  15. Durkes, D.E.
  16. Foudray, M.C.
  17. Kantarjian, H.M.
  18. Dong, X.Q.
  19. Garcia-Manero, G.
Revue:
Cancer

ISSN: 1097-0142,  0008-543X

Année de publication: 2017

Volumen: 123

Número: 24

Pages: 4851-4859

Type: Article

DOI: 10.1002/CNCR.30949 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus